Active, Not Recruiting
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
NCT03513484
- Conditions
- Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, FLT3 Internal Tandem Duplication, Fibroblast Growth Factor Basic Form Measurement, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States